Skip to content

Clinical trials

Phase 2 Immune System Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 2 Country / region: Czechia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20171
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Active, not recruiting1
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Amgen1
Cogent Biosciences, Inc.1
Diamyd Medical AB1
European Association of Urology Research Foundation1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases7
Autoimmune Diseases2
Dermatitis2
Dermatitis, Atopic2
Eczema2
Skin Diseases2
Connective Tissue Diseases1
Demyelinating Diseases1
Diabetes Mellitus1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.